Phosphagenics and Nestle Nutrition Enters Research Agreement
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Food and Agriculture by ruth on April 30, 2006

Phospa E is patented vitamin E phosphate, said to protect the antioxidant potential of vitamin E during absorption, transport and storage in the body. It is currently only marketed in the US, Canada and Indonesia by Zila Nutraceuticals, which markets it as Ester-E.
Nestle Nutrition may use Phospha E to develop nutritional products that target the prevention and treatment of metabolic syndrome, a group of risk factors for heart disease, including excessive weight, high blood pressure, high blood sugar and triglyceride concentrations, and other factors contributing to cardiovascular disease
.See Nutraingredients.com for a feature report. Other public details of the agreement may be found here.
Permalink: Phosphagenics and Nestle Nutrition Enters Research Agreement
Tags:
nutrition vitamin biotech nestle news nestle+nutrition phosphagenics+nestle enters+research
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/21026








